Standard X, a London-based startup building the infrastructure needed to manufacture rare medical materials, has raised £10m in seed funding. The round was led by Vsquared and East X, which have backed Neura Robotics and Proxima Fusion respectively.

Standard X's technology aims to make medical isotopes more accessible. The company is developing a microreactor system that can produce isotopes on-site, reducing reliance on aging nuclear reactors. The startup plans to deploy its first unit at a hospital in the UK.

The funding will support the development of its microreactor technology and expansion of its team. Standard X's founders include experts from the nuclear and medical fields. The company is targeting a market worth billions in diagnostic imaging and cancer treatment.